BFRGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRGW

BullFrog AI Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.53+0.01 (+2.81%)

Close on Oct 19, 2026

Market cap: $9.92M
P/E (TTM): –
Dividend yield: –

BullFrog AI Holdings, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q2 2021 2021-06-15	Q4 2020 2020-12-31
Cash & Equivalents	6.92	5.08	2.18	1.99	2.58	3.80	5.44	4.24	5.61	7.01	2.62	3.86	5.46	5.42	0.06	0.04	0.24	0.02	0.01	–	0.01
Cash & Short-Term Investments	6.92	5.08	2.18	1.99	2.58	3.80	5.44	4.24	5.61	7.01	2.62	3.86	5.46	5.42	0.06	0.04	0.24	0.02	0.01	–	0.01
Receivables	–	–	–	0.06	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	0.34	0.23	0.40	0.49	0.23	0.28	0.11	0.36	0.46	0.63	0.15	0.35	0.58	0.81	0.02	–	–	–	–	–	–
Total Current Assets	7.47	5.32	2.58	2.54	2.70	4.08	5.55	4.60	6.07	7.64	2.77	4.21	6.04	6.23	0.07	–	–	–	0.01	–	–
Property, Plant & Equipment	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	–	–	–	–	–	–
Accumulated Depreciation	–	–	-0.01	–	–	–	0.00	–	–	–	0.00	–	–	–	0.00	–	–	–	–	–	–
Machinery & Equipment	–	–	0.01	–	–	–	0.01	–	–	–	0.01	–	–	–	0.01	–	–	–	–	–	–
Long-Term Investments	0.12	0.12	0.12	0.06	0.06	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Assets	7.69	5.54	2.81	2.70	2.87	4.09	5.55	4.60	6.08	7.65	2.78	4.21	6.04	6.23	0.08	–	–	–	0.01	–	–
Accounts Payable	0.17	0.22	0.17	0.17	0.18	0.21	0.44	0.09	0.08	0.15	0.10	0.11	0.49	0.64	0.54	–	–	–	0.07	–	–
Accrued Expenses	0.45	0.30	0.50	0.53	0.36	0.46	0.15	0.52	0.27	0.18	0.08	0.12	0.20	0.31	0.98	–	–	–	0.07	–	–
Short-Term Debt	–	–	–	0.06	0.11	0.16	–	0.17	0.34	0.51	–	0.21	0.42	0.63	–	–	–	–	0.05	0.03	–
Current Debt	–	–	–	0.06	0.11	0.16	–	0.17	0.34	0.51	–	0.21	0.42	0.63	–	–	–	–	0.05	0.03	–
Deferred Revenue (Current)	–	–	–	–	–	–	–	–	–	–	–	–	0.03	0.03	0.03	–	–	–	0.01	–	–
Other Current Liabilities	0.09	0.13	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	0.71	0.65	0.67	0.76	0.68	0.84	0.59	0.78	0.69	0.84	0.18	0.45	1.14	1.61	3.14	–	–	–	1.02	–	–
Total Liabilities	0.71	0.65	0.67	0.76	0.68	0.84	0.59	0.78	0.69	0.84	0.18	0.45	1.14	1.61	3.14	–	–	–	1.02	–	–
Total Debt	–	–	–	0.06	0.11	0.16	–	0.17	0.34	0.51	–	0.21	0.42	0.63	–	–	–	–	0.05	0.03	–
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–	–	–	–	–	–
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–	–	–	0.00	–	–
Additional Paid-In Capital	33	33	25	2.00	2.80	22	22	19	19	18	12	12	12	10	1.34	–	–	–	0.59	–	–
Retained Earnings	-26	-25	-23	-22	-20	-19	-17	-15	-13	-12	-9.75	-8.46	-7.21	-5.72	-4.40	–	–	–	-1.60	–	–
Shareholders' Equity	6.99	4.89	2.14	1.94	2.19	3.25	4.96	3.82	5.39	6.80	2.59	3.77	4.90	4.62	-3.06	-2.41	-1.89	-1.55	-1.01	–	-0.54
Total Equity	6.99	4.89	2.14	1.94	2.19	3.25	4.96	3.82	5.39	6.80	2.59	3.77	4.90	4.62	-3.06	-2.41	-1.89	-1.55	-1.01	–	-0.54
Total Liabilities & Equity	7.69	5.54	2.81	2.70	2.87	4.09	5.55	4.60	6.08	7.65	2.78	4.21	6.04	6.23	0.08	–	–	–	0.01	–	–
Shares Outstanding(shares)	19	18	11	10	9.63	9.42	9.11	7.85	7.85	7.85	6.09	6.09	6.09	5.66	4.02	–	–	–	4.62	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 18.8%
Operating margin: -5230.2%
Net margin: -5139.7%
Return on equity, FY2025: -183.0%

Financial strength

Current ratio: 10.57
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 979.1%

Valuation

P/E ratio: –
Price to sales: 84.99
Price to book: 1.42
Dividend yield: –